YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis

Metabolism. 2019 Jul:96:33-45. doi: 10.1016/j.metabol.2019.04.013. Epub 2019 Apr 25.

Abstract

Background: Renal fibrosis promotes the development of diabetic nephropathy (DN). A growing number of studies have reported that Yin Yang 1 (YY1), which is involved in cellular proliferation and differentiation, plays a crucial role in the pathogenesis of many diseases, such as pulmonary fibrosis, hepatic steatosis and cancer.

Methods: We detected the expression of YY1 under various glucose concentration and time gradient conditions. Rapamycin was used to verify the mTORC1/p70S6K/YY1 signaling pathway in HK-2 cells. We used db/db mice to examine the connection between renal fibrosis and YY1. A luciferase assay and chromatin immunoprecipitation (ChIP) assay were used to identify whether YY1 directly regulated α-SMA by binding to the α-SMA promoter. RNA silencing and overexpression were performed by using a YY1 expression/knockdown plasmid to investigate the function of YY1 in renal fibrosis of DN.

Results: YY1 expression and subsequent nuclear translocation were upregulated in a glucose- and time-dependent manner via the mTORC1/p70S6K signaling pathway in HK-2 cells. YY1 expression and nuclear translocation was significantly upregulated in db/db mice. Furthermore, YY1 upregulated α-SMA expression and activity in high-glucose-cultured HK-2 cells. Overexpression of YY1 promoted renal fibrosis in db/m mice mainly by upregulating α-SMA expression and inducing epithelial-mesenchymal transition (EMT) in vitro and in vivo. Finally, downregulation of YY1 reversed renal fibrosis by improving EMT in vivo and in vitro.

Conclusions: These results reveal that upregulation of YY1 plays a critical role in HG-induced deregulation of EMT-associated protein expression, which finally results in renal fibrosis of DN. Therefore, decreasing YY1 expression might represent a new therapeutic target for diabetic nephropathy-induced renal fibrosis.

Keywords: Diabetic nephropathy; Epithelial-mesenchymal transition; Renal fibrosis; YY1; α-SMA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Cell Line
  • Diabetic Nephropathies / complications
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / pathology
  • Epithelial-Mesenchymal Transition / drug effects
  • Fibrosis
  • Gene Expression Regulation / drug effects
  • Gene Silencing
  • Glucose / pharmacology
  • Humans
  • Male
  • Mechanistic Target of Rapamycin Complex 1 / drug effects
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Protein Transport / drug effects
  • Signal Transduction / drug effects
  • YY1 Transcription Factor / biosynthesis
  • YY1 Transcription Factor / drug effects*
  • YY1 Transcription Factor / genetics

Substances

  • Acta2 protein, mouse
  • Actins
  • YY1 Transcription Factor
  • YY1 protein, human
  • Yy1 protein, mouse
  • Mechanistic Target of Rapamycin Complex 1
  • Glucose